ELLINGTON MANAGEMENT GROUP LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 78 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$356,000
+256.0%
60,600
+248.3%
0.03%
+85.7%
Q2 2017$100,000
-32.4%
17,400
-32.0%
0.01%
+180.0%
Q1 2017$148,000
-3.9%
25,600
-12.6%
0.01%
-78.3%
Q4 2016$154,000
-4.9%
29,300
-19.3%
0.02%
-50.0%
Q3 2015$162,000
-8.5%
36,300
+46.4%
0.05%
+24.3%
Q1 2015$177,00024,8000.04%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
JBF Capital, Inc. 520,553$161,0000.03%
Kalos Management, Inc. 43,940$13,0000.01%
ACADIAN ASSET MANAGEMENT LLC 1,351,000$419,0000.00%
Quilter Plc 60,546$19,0000.00%
ALBION FINANCIAL GROUP /UT 12,000$4,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$7,0000.00%
MORGAN STANLEY 1,900$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$8,0000.00%
BlackRock Inc. 645,611$200,0000.00%
Bank of New York Mellon Corp 137,500$43,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders